A detailed history of Bank Of Montreal transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Bank Of Montreal holds 220,518 shares of IONS stock, worth $9.01 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
220,518
Previous 222,818 1.03%
Holding current value
$9.01 Million
Previous $9.66 Million 8.8%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$36.45 - $47.7 $83,835 - $109,710
-2,300 Reduced 1.03%
220,518 $10.5 Million
Q1 2024

May 13, 2024

SELL
$42.03 - $53.55 $23,999 - $30,577
-571 Reduced 0.26%
222,818 $9.66 Million
Q4 2023

Feb 08, 2024

SELL
$43.39 - $51.63 $148,914 - $177,194
-3,432 Reduced 1.51%
223,389 $11.3 Million
Q3 2023

Nov 01, 2023

BUY
$38.5 - $47.13 $142,065 - $173,909
3,690 Added 1.65%
226,821 $10.3 Million
Q2 2023

Aug 02, 2023

BUY
$34.73 - $43.33 $40,043 - $49,959
1,153 Added 0.52%
223,131 $9.16 Million
Q1 2023

Jun 13, 2024

SELL
$33.58 - $41.2 $298,425 - $366,144
-8,887 Reduced 3.99%
213,931 $7.65 Million
Q4 2022

Feb 01, 2023

SELL
$37.12 - $46.52 $3.77 Million - $4.72 Million
-101,551 Reduced 31.39%
221,978 $8.38 Million
Q3 2022

Nov 10, 2022

BUY
$36.54 - $48.66 $3.34 Million - $4.45 Million
91,537 Added 39.46%
323,529 $15.1 Million
Q2 2022

Aug 11, 2022

SELL
$31.71 - $43.0 $1.16 Million - $1.57 Million
-36,505 Reduced 13.6%
231,992 $9.22 Million
Q1 2022

May 12, 2022

BUY
$29.88 - $37.04 $1.17 Million - $1.45 Million
39,090 Added 17.04%
268,497 $9.58 Million
Q4 2021

Feb 11, 2022

SELL
$25.61 - $35.1 $519,806 - $712,424
-20,297 Reduced 8.13%
229,407 $7.17 Million
Q3 2021

Nov 12, 2021

SELL
$33.54 - $40.55 $4.42 Million - $5.34 Million
-131,781 Reduced 34.54%
249,704 $8.49 Million
Q2 2021

Aug 12, 2021

BUY
$34.54 - $47.25 $13.2 Million - $18 Million
381,485 New
381,485 $15.1 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.8B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.